Fingerprint
Dive into the research topics of 'Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically